论文部分内容阅读
强生制药于2008-10-22宣布,FDA批准扩大其生产的Prezista(或darunavir)的使用范围,即Prezista与其他抗艾滋病药物联用治疗首次接受治疗的艾滋病患者。
Johnson & Johnson Pharmaceuticals announced on October 10, 2008 that the FDA approved the expansion of its use of Prezista (or darunavir), the first treatment of AIDS patients with Prezista in combination with other anti-HIV drugs.